Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

Belgium

ZAS Augustinus, Antwerp

Antwerp University Hospital, Antwerp

University Hospital Brussels, Brussels

Ghent University Hospital, Ghent

Jessa Ziekenhuis, Hasselt

University Hospitals Leuven, Leuven